Grow Ozempic at Home
- Imagine a world where access to life-changing medication isn't dictated by cost or availability.
- The Phytogene project utilizes *Nicotiana benthamiana* plants to produce glucagon-like Peptide-1 (GLP-1) Receptor Agonists, the class of drugs that includes the widely popular type-II diabetes and weight-loss medication,...
- By using plants as miniature drug factories,Phytogene seeks to address the environmental and economic concerns associated with conventional pharmaceutical manufacturing.
The Future of Pharmaceuticals? Grow Your Own Ozempic-like Medication at Home
Table of Contents
- The Future of Pharmaceuticals? Grow Your Own Ozempic-like Medication at Home
- Grow Your Own Ozempic? Exploring teh Phytogene Project
- what is the Phytogene Project?
- How Does Biopharming Work in the Phytogene Project?
- What Problem is Phytogene Trying to Solve?
- What Inspired the Phytogene Project?
- Why Was There an Ozempic Shortage?
- Has the Ozempic Shortage Been Resolved?
- What are the Potential Benefits of Phytogene/Biopharming?
- What are GLP-1 Agonists?
- What is Nicotiana benthamiana?
- Has Phytogene Been Tested on Humans?
- What Future Research is Planned for Phytogene?
- What Recognition Has the phytogene Project Received?
- Who is Involved in the Phytogene Project?
- Is it Possible to Grow Ozempic at Home Right Now?
- summary of the Phytogene Project
- How Can I Stay Updated on the Phytogene Project?
Imagine a world where access to life-changing medication isn’t dictated by cost or availability. A team of students at the university of Ottawa is working to make this a reality. Their innovative project, Phytogene, explores the possibility of producing drugs like Ozempic in plants, offering a sustainable and accessible option to customary pharmaceutical methods.
Phytogene: biopharming for a Sustainable Future
The Phytogene project utilizes *Nicotiana benthamiana* plants to produce glucagon-like Peptide-1 (GLP-1) Receptor Agonists, the class of drugs that includes the widely popular type-II diabetes and weight-loss medication, Ozempic. This approach, known as biopharming, aims to revolutionize drug production.
By using plants as miniature drug factories,Phytogene seeks to address the environmental and economic concerns associated with conventional pharmaceutical manufacturing.
Addressing Ozempic Shortages Through Innovation
The project was inspired by the recent Ozempic shortage, which highlighted the vulnerabilities in the current pharmaceutical supply chain.Biotechnology and biomedical science major Victor Boddy,the project lead,explained:
Inspired by the recent Ozempic shortage,we built a proof-of-concept model system that expresses functional GLP-1 agonists in plants.
Victor Boddy, University of Ottawa
The goal is ambitious: to empower individuals to grow their own treatments at home, free from the constraints of insurance, cost, and availability.
The Impact of Ozempic Shortages
Since 2022, the global surge in demand for Ozempic as a weight-loss solution has led to widespread shortages. This situation has raised concerns among healthcare professionals, not only for patients who rely on the medication for diabetes management but also due to the rise of counterfeit drugs.
Some individuals have even resorted to traveling long distances to obtain prescriptions,underscoring the desperation caused by the shortage. While the FDA announced in February 2025 that the semaglutide medicine shortage had been resolved, the phytogene project offers a potential long-term solution to prevent future crises.
A Sustainable Solution for Medication Access
Teagan Thomas, project co-leader, emphasizes the sustainable nature of Phytogene:
Phytogene offers a unique, sustainable approach to biotechnology by providing an environmentally kind solution to the critical crisis of medication access.
Teagan Thomas, University of Ottawa
The team is actively seeking support from venture capitalists and scientific advisors to further develop the project into a commercially viable solution.
International Recognition at iGEM Grand jamboree
The Phytogene team showcased their project at the iGEM Grand Jamboree in Paris, competing against 430 international teams and winning a gold medal. This recognition highlights the potential of their innovative approach to pharmaceutical production.
Future Research and Progress
While the prospect of growing Ozempic at home is exciting, it’s crucial to remember that the project is still in its early stages. The plant-derived extracts have not yet undergone human trials.
The team is currently analyzing blood glucose and insulin levels to assess the response to the plant-derived medication. Further research is planned, including bioactivity assays to test the drug’s effectiveness on human cells.
we are currently analyzing blood glucose and insulin levels to assess response. We also plan to conduct bioactivity assays to test the drug’s effectiveness on human cells.
Teagan Thomas, University of Ottawa
The Phytogene project represents a important step towards a more sustainable and accessible future for pharmaceutical production. If accomplished, it could revolutionize the way we access life-saving medications.
Grow Your Own Ozempic? Exploring teh Phytogene Project
the University of Ottawa’s Phytogene project is making waves with its innovative approach to pharmaceutical production. Imagine growing your own medications at home! This Q&A explores the project, its goals, and its potential impact on the future of healthcare.
what is the Phytogene Project?
The Phytogene project is a student-led initiative at the University of Ottawa focused on producing drugs,specifically glucagon-like Peptide-1 (GLP-1) Receptor Agonists (like ozempic),in plants (Nicotiana benthamiana). This process, known as biopharming, aims to offer a sustainable and accessible alternative to customary pharmaceutical manufacturing.
in simple terms: Phytogene is trying to turn plants into tiny drug factories.
How Does Biopharming Work in the Phytogene Project?
The project utilizes Nicotiana benthamiana plants to produce GLP-1 receptor agonists. By manipulating the plant’s genetic makeup, the team aims to stimulate the plant to produce the desired drug compounds.
What Problem is Phytogene Trying to Solve?
Phytogene primarily addresses two critical issues:
Medication accessibility: High costs, insurance limitations, and supply chain vulnerabilities can restrict access to vital medications.
Sustainability of pharmaceutical production: Traditional pharmaceutical manufacturing can have notable environmental and economic drawbacks.
What Inspired the Phytogene Project?
The project was directly inspired by the Ozempic shortage that began in 2022. This shortage highlighted the fragility of current pharmaceutical supply chains and the need for alternative production methods.
Why Was There an Ozempic Shortage?
The Ozempic shortage was driven by a global surge in demand for the drug,notably for its off-label use as a weight-loss solution. This increased demand strained supply chains, leading to shortages and concerns about counterfeit medications.
Has the Ozempic Shortage Been Resolved?
While the FDA announced in February 2025 that the semaglutide medicine shortage had been resolved,the Phytogene project offers a potential long-term solution to prevent future crises.
What are the Potential Benefits of Phytogene/Biopharming?
Increased accessibility: Individuals could possibly grow their own medications, reducing reliance on traditional pharmaceutical companies and insurance.
Cost reduction: Production costs could be substantially lower, making medications more affordable.
Sustainability: Plant-based production is potentially more environmentally friendly than traditional manufacturing.
What are GLP-1 Agonists?
GLP-1 (glucagon-like peptide-1) agonists are a class of drugs that mimic the effects of the GLP-1 hormone in the body. They are primarily used to treat type 2 diabetes by:
Stimulating insulin release
Suppressing glucagon secretion
Slowing gastric emptying
Ozempic is a well-known example of a GLP-1 agonist.
What is Nicotiana benthamiana?
Nicotiana benthamiana is a species of tobacco plant commonly used in scientific research, especially in the field of plant biotechnology.It is favored because it is easy to genetically modify and can quickly produce large quantities of proteins.
Has Phytogene Been Tested on Humans?
No, the plant-derived extracts from the Phytogene project have not yet undergone human trials. The project is still in its early stages.
What Future Research is Planned for Phytogene?
The Phytogene team is currently focused on:
Analyzing blood glucose and insulin levels in response to the plant-derived medication.
Conducting bioactivity assays to test the drug’s effectiveness on human cells.
What Recognition Has the phytogene Project Received?
The Phytogene team showcased their project at the iGEM Grand Jamboree in Paris, competing against 430 international teams and winning a gold medal.
Who is Involved in the Phytogene Project?
Key members of the Phytogene project include:
Victor Boddy: Project Lead, Biotechnology and Biomedical Science Major
teagan Thomas: Project Co-leader
Is it Possible to Grow Ozempic at Home Right Now?
No. While the Phytogene project is promising, it is indeed still in the early stages of research and growth. You cannot currently grow Ozempic or similar medications at home.
summary of the Phytogene Project
| Feature | Description |
| ——————- | ——————————————————————————————————————————————- |
| Project Goal | Produce GLP-1 agonists (like Ozempic) in plants for sustainable and accessible medication |
| technology | Biopharming using Nicotiana benthamiana plants |
| Inspiration | Ozempic shortage of 2022 |
| Current Status | pre-clinical research; analyzing blood glucose, insulin levels, and conducting bioactivity assays |
| Future Plans | Further research, including bioactivity assays on human cells, venture capital, and scientific advisors to develop a commercial solution. |
| Benefits | Increased accessibility, potential cost reduction, sustainable production |
How Can I Stay Updated on the Phytogene Project?
The best way to stay updated is to subscribe to newsletters from the University of Ottawa’s science or research departments, or keep an eye on news related to the iGEM competition.